Medicare Coverage of FDA Approved “Critical Breakthrough Products”

AAHD and the Lakeshore Foundation have joined the ITEM (Independence Through Enhancement of Medicare and Medicaid) Coalition letter to Congress supporting HR 1691, a bill that would authorize a 4 year transitional payment of FDA approved “critical breakthrough products.” The December 12 ITEM Coalition letter is here: PDF.